NCT03092310View on ClinicalTrials.gov

Feasibility Evaluation of an Artificial Pancreas With Glucose Prediction Trust Index

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 20, 2017

Primary Completion Date

December 20, 2017

Study Completion Date

December 20, 2017

Conditions
Type 1 Diabetes Mellitus
Interventions
DEVICE

Artificial Pancreas Device

Artificial Pancreas Device

Trial Locations (1)

93105

William Sansum Diabetes Center, Santa Barbara

All Listed Sponsors
collaborator

Harvard University

OTHER

lead

Sansum Diabetes Research Institute

OTHER

NCT03092310 - Feasibility Evaluation of an Artificial Pancreas With Glucose Prediction Trust Index | Biotech Hunter | Biotech Hunter